Concepedia

Craig H. Moskowitz

CH

196

Publications

21.4K

Citations

70

H-Index

1992

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Dana-Farber Cancer Institute

Sylvester Comprehensive Cancer Center

City Of Hope National Medical Center

Craig H. Moskowitz is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pathology.

ORCID

Top concepts

Publications per year

1992–2024

196

Publications

196

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Christian Gisselbrecht, Nicolas Mounier, Devinder Gill et al. · Journal of Clinical Oncology · 2010 · 1.6K citations · Full text

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

Anas Younes, Ajay K. Gopal, Scott E. Smith et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

Robert Chen, Pier Luigi Zinzani, Michelle A. Fanale et al. · Journal of Clinical Oncology · 2017 · 967 citations · Full text

, , +18

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

Craig H. Moskowitz, Auayporn Nademanee, Tamás Masszi et al. · The Lancet · 2015 · 726 citations · Full text

, , +10

Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure

Philippe Armand, Margaret A. Shipp, Vincent Ribrag et al. · Journal of Clinical Oncology · 2016 · 667 citations · Full text

Rows per page

1–5 of 196